- Home
- RVP vs ENLV Comparison
RVP vs ENLV Comparison
Compare RVP & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- ENLV
- Stock Information
- Founded
- RVP 1994
- ENLV 2005
- Country
- RVP United States
- ENLV Israel
- Employees
- RVP 227
- ENLV N/A
- Industry
- RVP Medical/Dental Instruments
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- RVP Health Care
- ENLV Health Care
- Exchange
- RVP Nasdaq
- ENLV Nasdaq
- Market Cap
- RVP 19.8M
- ENLV 23.7M
- IPO Year
- RVP 2001
- ENLV 1995
- Fundamental
- Price
- RVP $0.67
- ENLV $1.13
- Analyst Decision
- RVP
- ENLV Strong Buy
- Analyst Count
- RVP 0
- ENLV 2
- Target Price
- RVP N/A
- ENLV $10.00
- AVG Volume (30 Days)
- RVP 31.2K
- ENLV 86.1K
- Earning Date
- RVP 08-13-2025
- ENLV 05-30-2025
- Dividend Yield
- RVP N/A
- ENLV N/A
- EPS Growth
- RVP N/A
- ENLV N/A
- EPS
- RVP N/A
- ENLV N/A
- Revenue
- RVP $33,745,343.00
- ENLV N/A
- Revenue This Year
- RVP N/A
- ENLV N/A
- Revenue Next Year
- RVP N/A
- ENLV N/A
- P/E Ratio
- RVP N/A
- ENLV N/A
- Revenue Growth
- RVP N/A
- ENLV N/A
- 52 Week Low
- RVP $0.56
- ENLV $0.81
- 52 Week High
- RVP $1.21
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- RVP 45.53
- ENLV 59.53
- Support Level
- RVP $0.63
- ENLV $0.90
- Resistance Level
- RVP $0.68
- ENLV $1.30
- Average True Range (ATR)
- RVP 0.04
- ENLV 0.09
- MACD
- RVP 0.00
- ENLV 0.01
- Stochastic Oscillator
- RVP 31.56
- ENLV 62.47
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.